Nima Farzan
Insider
IndividualSelling only1 10b5-1 trade
- 2026
- Jun 8, 2026
- 2
Filings (90d)
0
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Nima Farzan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Esther Cho - $124K in KROS purchases and sales in the last 12 months
- Jasbir Seehra - $113K in KROS purchases and sales in the last 12 months
- Lorena Raquel Lerner - $100K in KROS purchases and sales in the last 12 months
- Keith Regnante - $77K in KROS purchases and sales in the last 12 months
- Jean Jacques Bienaime - $76K in KROS purchases and sales in the last 12 months
- Julius Knowles - $28K in KROS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Nima Farzan?
Nima Farzan is a corporate insider of Keros Therapeutics, Inc. (KROS). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Nima Farzan last file a Form 4?
The most recent primary Form 4 on record is dated 8 June 2026, one of 2 filings going back to 2026.
Has Nima Farzan been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($28K) across all tracked filings.
